Section 1. L’incrimination d’une violence à l’encontre des prostitués
A. Une extension de la pénalisation à l’ensemble des clients
2. L’extension de la protection à toutes les personnes prostituées
Observou-se uma resposta imune sistêmica e de mucosa desenvolvida por um mecanismo de entrega sublingual do antígeno do CPV 2 apenas após a segunda imunização.
Desenvolveu-se um mecanismo de entrega sublingual com o antígeno do CPV 2
Houve aumento da produção de Ig A secretora total a partir da primeira imunização
Houve resposta imune sistêmica por IgG específico a partir da segunda imunização.
A mucoadesividade é importante para o reconhecimento de patógenos e desenvolvimento de uma resposta imune efetiva.
REFERÊNCIAS
ABBAS, A. K.; LICHTMAN, A. H.; PILLAI, S. Imunologia Celular e Molecular, 6a ed. Rio de Janeiro: Elsevier, 2007.
ABDELWAHED, W.; DEGOBERT, G.; STAINMESSE, S.; FESSI, H. Freeze- drying of nanoparticles: Formulation, process and storage considerations.
Advanced Drug Delivery Reviews, v. 58, n. 15, p. 1688-1713, 2006.
ACTOR, J. K. Imunologia e Microbiologia. Rio de Janeiro: Elsevier, 184p, 2007.
AGNIHOTRI, S. A.; MALLIKARJUNA, N. N.; AMINABHAVI, T. M. Recent
advances on chitosan-based micro- and nanoparticles in drug delivery. Journal
of Controlled Release: Official Journal of the Controlled Release Society,
v. 100, n. 1, p. 5-28, 2004.
AMIDI, M.; MASTROBATTISTA, E.; JISKOOT, W.; HENNINK, W. E. Chitosan- based delivery systems for protein therapeutics and antigens. Advanced Drug
Delivery Reviews, v. 62, n. 1, p. 59-82, 2010.
AMORIJ,J.-P.; HINRICHS, W.L.; FRIJLINK, H.W.; WILSCHUT, J.C.;
HUCKRIEDE , A. Needle-free influenza vaccination. The Lancet Infectious
Diseases. , v.10, p.699-711, 2010.
AMORIJ, J.- P.; KERSTEN, G.F.A.; SALUJA, V.; TONNIS, W. F.; HINRICHS, W.L.J.; SLÜTTER, B.; BAL, S.M.; BOUWSTRA, J.A.; HUCKRIEDE,A.;
JISKOOT,W.Towards Tailored Vaccine Delivery: Needs, Challenges and Perspectives. Journal of Controlled Release, p.1-14, 2012a.
AMUGUNI, H.; LEE, S.; KERSTEIN, K.; BROWN, D.; BELITSKY, B.; HERRMANN, J.; KEUSCH, G.; SONENSHEIN, A.; TZIPORI, S.Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
Microbes and Infection, v.14, p. 447-56, 2012.
ANACAK, Y.; MILLER, R. C.; CONSTANTINOU, N.; et al. Primary Mucosa- Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study. International Journal of Radiation
Oncology*Biology*Physics, v. 82, p. 315 – 320, 2012.
APPEL, M.; SCOTT, F.; CARMICHAEL, L. Isolation and immunization studies of a canine parvo-like virus from dogs with haemorrhagic enteritis. Veterinary
Record, v. 105, n.8, p. 156 – 159, 1979.
ASANE, G.S.; NIRMAL, S.A.; RASAL, K.B.; NAIK, A.A.; MAHADIK, M.S.; RAO, Y.M. Polymers for mucoadhesive drug delivery system: a current status. Drug
AZIZ, M. A.; MIDHA, S.; WAHEED, S. M.; BHATNAGAR, R. Oral vaccines: new needs, new possibilities. BioEssays, v. 29, n. 6, p. 591-604, 2007.
BAUMANN, J. PARK, C. G.; MANTIS, N. J. Recognition of secretory IgA by DC- SIGN: Implications for immune surveillance in the intestine. Immunology
Letters, v. 131, n. 1, p. 59-66, 2010
BINN, L.; LAZAR,E.; EDDY, G.; KAJIMA, M. Recovery and characterization of a minute virus of canines. Infection and Immunity, v.1, p. 503 – 508, 1970. BORGES, O.; TAVARES, J.; DE SOUSA, A.; BORCHARD, G.; JUNGINGER, H.E.; CORDEIRO-DA-SILVA, A. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into
alginate-coated chitosan nanoparticles. European Journal of Pharmaceutical
Sciences, v. 32, n. 4-5, p. 278-290, 2007.
BRANDTZAEG, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine, v. 25, n. 30, p. 5467-5484, 2007
BRANDTZAEG, P. The Mucosal Immune System and Its Integration with the Mammary Glands. The Journal of Pediatrics, v. 156, n. 2, Supplement 1, p. S8-S15, 2010.
BUONAVOGLIA, C.; MARTELLA, V.; PRATELLI, A.; TEMPESTA, M.;CAVALLI, A.; BUONAVOGLIA, D.; BOZZO, G.; ELIA, G.; DECARO, N.; CARMICHAEL, L. Evidence for evolution of canine parvovirus type 2 in Italy. Journal of General
Virology, v. 82, n. 12, p. 3021-3025, 2001.
CARMICHAEL, L.; BINN, L. New enteric viruses in the dog. Advances in
Veterinary Science and Comparative Medicine, v. 25, p. 1- 37, 1981.
CARPENTER, J. F.; PIKAL, M. J.; CHANG, B. S.; RANDOLPH, T. W. Rational design of stable lyophilized protein formulations: some practical advice.
Pharmaceutical Research, v. 14, n. 8, p. 969-975, 1997.
CHACÓN, M.; MOLPECERES, J.; BERGES, L.; GUZMÁN, M.; ABERTURAS, M. R. Stability and freeze-drying of cyclosporine loaded poly(, lactide-glycolide) carriers. European Journal of Pharmaceutical Sciences, v. 8, n. 2, p. 99-107, 1999.
CHAPLIN, D. D. Overview of the immune response. Journal of Allergy and
Clinical Immunology, v. 125, n. 2, Supplement 2, p. S3-S23, 2010.
CHO, H.-J.; Kim, J.-Y.; LEE Y.; KIM, J.M.; KIM, Y.B.; CHUN, T.; OH, Y.-K. Enhanced humoral and cellular immune responses after sublingual
immunization against human papillomavirus 16 L1 protein with adjuvants.
Vaccine, v. 28, 2598-2606, 2010.
CSABA, N.; KÖPING-HÖGGÅRD, M.; ALONSO, M. J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA
delivery. International Journal of Pharmaceutics, v. 382, n. 1-2, p. 205-214, 2009.
COSTANTINO, H. R.; PIKAL, M. J. Lyophilization of biopharmaceuticals. Springer, 2004.
COTMORE, S. F.; TATTERSALL, P. DNA replication in the autonomous parvoviruses. Seminars in Virology, v. 6, n. 5, p. 271-281. doi:
10.1006/smvy.1995.0033, 1995.
ÇUBURU, N.; KWEON, M.; SONG, J.; ET AL. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine, v. 25, n. 51, p. 8598-8610, 2007.
DAY, M. Immune System Development in the Dog and Cat. Journal of
Comparative Pathology, v. 137, n. Supplement 1, p. S10-S15, 2007.
DENNEHY, P. H. Rotavirus vaccines-An update. Vaccine, v. 25, n. 16, p. 3137- 3141, 2007.
DE MAGISTRIS, M. T. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Advanced Drug Delivery Reviews, v. 58, n. 1, p. 52-67, 2006. DESAI, M. P.; LABHASETWAR, V.; WALTER, E.; LEVY, R. J.; AMIDON, G. L. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent. Pharmaceutical Research, v. 14, n. 11, p. 1568-1573, 1997. DESARIO, C.; DECARO, N.; CAMPOLO, M.; CAVALLI, A.; CIRONE, F.; ELIA, M.;MARTELLA, V.; LORUSSO, E.; CAMERO, M.; BUONAVOGLIA, C. Canine parvovirus infection: Which diagnostic test for virus? Journal of Virological
Methods 126, 179-185, 2005.
DIETRICH, G.; GRIOT-WENK, M.; METCALFE, I. C.; LANG, A. B.; VIRET, J. Experience with registered mucosal vaccines. Vaccine, v. 21, n. 7-8, p. 678- 683, 2003.
EDSMAN, K.; HAGERSTROM, H. Pharmaceutical applications of mucoadhesion for the non-oral routes. Journal of Pharmacy and
Pharmacology, v.57, p. 3–22, 2005.
FENNER, F.; BACHMANN, P. A.; GIBBS, E. P. J.; MURPHY, F. A.;
STUDDERT, M. J.; WHITE, D. O. Virología Veterinaria. Editora Acribia, 691p., 1992.
FRANKS, F. Freeze-drying of bioproducts: putting principles into practice.
European Journal of Pharmaceutics and Biopharmaceutics, v. 45, n. 3, p.
GAN, Q.; WANG, T. Chitosan nanoparticle as protein delivery carrier-- Systematic examination of fabrication conditions for efficient loading and release. Colloids and Surfaces B: Biointerfaces, v. 59, n. 1, p. 24-34, 2007. GODDARD, A.; LEISEWITZ, A. L. Canine Parvovirus. Veterinary Clinics of
North America: Small Animal Practice, v. 40, n. 6, p. 1041-1053, 2010.
GREENE, C. E.; Infectious Diseases of the Dog and Cat, 3° edition, Saunders Elsevier, St. Louis, Missouri, U.S.A., 2006.
HAGIWARA, M. K.; JULY, J. R.; BACCARO, M. R.; ANGELO, M. J. O. Enterite hemorrágica em cães associada à infecção por um parvovirus. Arquivos do
Instituto Biológico - São Paulo, v. 47, p. 47-49, 1980.
HARRIS, D. C.; Análise Química Quantitativa, 5ª ed., LTC-Livros Técnicos e
Científicos Editora S.A.: Rio de Janeiro, 2001.
HEID, C. A.; STEVENS, J.; LIVAK, K. J.; WILLIAMS, P. M. Real time quantitative PCR. Genome Research, v. 6: 986-994, 1996.
HILLEMAN, M. R. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine, v. 18, n. 15, p. 1436-1447, 2000.
HOLMGREN, J.; CZERKINSKY, C. Mucosal immunity and vaccines. Nature
Medicine. v.11, p. 45-53, 2005.
HOSKINS, J.D. Update on canine parvoviral enteritis. Veterinary Medicine.v. 92(8):p.694–709, 1997.
HUEFFER, K.; PARRISH, C. R. Parvovirus host range, cell tropism and evolution. Current Opinion in Microbiology, v. 6, n. 4, p. 392-398. doi: 10.1016/S1369-5274(03)00083-3, 2003.
JACOBS, R. M.; WEISER, M. G.; HALL, R. L.; KOWALSKI, J. J.
Clinicopathologic features of canine parvoviral enteritis. Journal of the
American Animal Hospital Association, v. 16: 809-814, 1980.
JONES,T.C.; HUNT, R.D.; KING, N.W. Patologia Veterinária, 6a ed. Barueri:
Manole, cap.8, p.266-273, 2000.
JÓNSDÓTTIR, I. Maturation of Mucosal Immune Responses and Influence of Maternal Antibodies. Journal of Comparative Pathology, v. 137, n.
Supplement 1, p. S20-S26, 2007.
KEAN, T.; THANOU, M. Biodegradation, biodistribution and toxicity of chitosan.
Advanced Drug Delivery Reviews, v. 62, n. 1, p. 3-11, 2010.
KELLY, W. An enteric disease of dogs resembling feline panleucopenia.
KNOLL, M. Aufladepotentiel und Sekundäremission elektronenbestrahlter Körper. ZTech. Phys. v.16, 467-475, 1935.
KWEON, M. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine, v. 54, p. 1-5, 2011.
LAMM, C. G.; REZABEK, G. B. Parvovirus Infection in Domestic Companion Animals. Veterinary Clinics of North America: Small Animal Practice, v. 38, n. 4, p. 837-850, 2008.
LEBIEN, T. W.; TEDDER, T. F. B lymphocytes: how they develop and function.
Blood, v. 112, n. 5, p. 1570-1580, 2008.
LEMIALE, F.; KONG, W.; AKYUREK, L.; LING, X.; HUANG, Y.; CHAKRABARTI, B.; ECKHAUS, M.; NABEL, G. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human
immunodeficiency virus vaccine and localization in the central nervous system.
Journal of Virology, v. 77, p.10078 -10087, 2003.
LEVINE, M. M.; KAPER, J. B. Live oral vaccines against cholera: An update.
Vaccine, v. 11, n. 2, p. 207-212, 1993.
MACKAY, I. M.; MACKAY, J. F.; NISSEN, M. D.; SLOOTS, T. P. Real-time PCR: historyand fluorogenic chemistries. In: Real-time PCR in Microbiology.
From diagnosis tocharacterization. Mackay, I. M. Academic Press. 464p,
2007.
MACLAUGHLIN, S. Dr. Albert Sabin. Primary Care Update for OB/GYNS, v. 10, n. 3, p. 129-130, 2003.
MACPHERSON, A. J. HUNZIKER, L. MCCOY, K.; LAMARRE, A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes and Infection, v. 3, n. 12, p. 1021-1035, 2001. MANICKAN, E.; YU, Z.; ROUSE, B. T. DNA immunization of neonates induces immunity despite the presence of maternal antibody. Journal of Clinical
Investigation, v. 100, n. 9, p. 2371-2375, 1997.
MARTELLA, V.; CAVALLI, A.; DECARO, N. et al. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol, p.1243 - 1245, 2005.
MCCLUSKIE, M. J.; DAVIS, H. L. Mucosal immunization with DNA vaccines.
Microbes and Infection, v. 1, n. 9, p. 685-698, 1999.
MCVEY, S.; SHI, J. Vaccines in Veterinary Medicine: A Brief Review of History and Technology. Veterinary Clinics of North America: Small Animal
MIMS, C.A.; PLAYFAIR, J.H.; ROITT,I.M.; WAKELIN,D.; WILLIAMS, R.
Microbiologia Médica. São Paulo: Manole Ltda, p. 25.1-25.14, 1995.
MITRAGOTRI, S. Immunization without needles. Nature Reviews
Immunology, v. 5, n. 12, p. 905-916, 2005.
MOCHIZUKI, M.; SAN GABRIEL, M. V.; NAKATANI, H.; YOSHIDA, M.;
HARASAWA, R. Comparasion of polymerase chain reaction with virus isolation, haemagglutination assays for the detection of canine parvoviruses in faecal specimens. Research in Veterinary Science, v. 55, 60-63, 1993.
MOHAN RAJ, J.; MUKHOPADHYAY, H.; THANISLASS, J.; ANTONY, P.; PILLAI, R. Isolation, molecular characterization and phylogenetic analysis of canine parvovirus. Infection, Genetics and Evolution, v. 10, n. 8, p. 1237- 1241. doi: 10.1016/j.meegid.2010.08.005, 2010.
MORAES, M. P.; COSTA, P. R. S. Virologia Veterinária. Eduardo Flores, capítulo 14. Santa Maria: Ed. UFSM, 888p, 2007.
MOREIN, B.; ABUSUGRA, I.; BLOMQVIST, G. Immunity in neonates.
Veterinary Immunology and Immunopathology, v. 87, n. 3-4, p. 207-213,
2002.
MURPHY, F. A.; GIBBS, E. P.J.; HORZINEK, M. C.; STUDDERT, M. J.
Veterinary Virology, Academic Press, 3 ed., 629p., 1999.
MORRIS, G. A. CASTILE, J. SMITH, A. ADAMS, G. G.; HARDING, S. E. The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP) - chitosan nanoparticles. Carbohydrate
Polymers, v. 84, n. 4, p. 1430-1434, 2011.
NCBI / TAXONOMY BROWSER; endereço eletrônico:
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi Acesso em:
15/11/2011.
NEGRI, D. R.; RICCOMI, A.; PINTO, D.; VENDETTI, S.; ROSSI, A.; CICCONI, R.; RUGGIERO, P.; DEL GIUDICE, G.; DE MAGISTRIS,M.T. Persistence of mucosal and systemic immune responses following sublingual immunization.
Vaccine, v. 28, n. 25, p. 4175-4180, 2010.
NEZLIN, R. Animal and Human Immunoglobulins. In: The Immunoglobulins, New York: Academic Press, p.75-121, 1998.
OGRA, P. L. Ageing and its possible impact on mucosal immune responses.
Ageing Research Reviews, v. 9, n. 2, p. 101-106, 2010.
OHSHIMA, T.; KISHI, M.; MOCHIZUKI, M. Sequence analysis of an Asian isolate of minute virus of canines (canine parvovirus type 1). Virus Genes, v. 29, n. 3, p. 291-296. doi: 10.1007/s11262-004-7430-3, 2004.
OIEN, N. L.; BRIDEAU, R. J.; WALSH, E. E.; WATHEN, M. W. Induction of local and systemic immunity against human respiratory syncytial virus using a
chimeric FG glycoprotein and cholera toxin B subunit. Vaccine, v. 12, n. 8, p. 731-735, 1994.
OTTO, C.M.; DROBATZ, K.J.; SOTER, C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. Journal of
Veterinary Internal Medicine. v.11(2), p.65–70, 1997.
PALERMO,L.M.; HAFENSTEIN, S.L.; PARRISH, C.R. Purified Feline and Canine Transferrin Receptors Reveal Complex Interactions with the Capsids of Canine and Feline Parvoviruses That Correspond to Their Host. Journal of
Virology, v. 80(17), p. 8482-8492, 2006.
PASTORET, P. Challenges and Issues of Early Life Vaccination in Animals and Humans. Journal of Comparative Pathology, v. 137, n. Supplement 1, p. S2- S3, 2007.
PARRISH, C. R.; TRUYEN, U. Parvovirus Variation and Evolution. In: Origin
and Evolution of Viruses. London: Academic Press, p.421-439, 1999.
PAVOT, V.; ROCHEREAU, N.; GENIN, C.; VERRIER, B.; PAUL, S. New
insights in mucosal vaccine development. Vaccine, p.142-54, 2012.
PITOMBO, R. N. M.; Liofilização. In: Purificação de produtos
biotecnológicos . JUNIOR, A.P.; KILIKIAN, B.V. (org.); editora Manole, SP,
p.332 – 349, 2005.
POLLOCK, R.V.; CARMICHAEL, L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
Journal of the American Veterinary Medical Association. 180, p. 37–42, 1982.
POMARICO, L. DE SOUZA, I. P. R. CASTRO, G. F. B. DE A. et al. Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: A systematic review. Journal of Dentistry, v. 38, n. 1, p. 10-15, 2010.
POVEY, R. C. Distempter Vaccination of Dogs: Factors Which Could Cause Vaccine Failure. The Canadian Veterinary Journal, v. 27, n. 9, p. 321-323, 1986.
PRABAHARAN, M. Review Paper: Chitosan Derivatives as Promising Materials for Controlled Drug Delivery. Journal of Biomaterials Applications, v. 23, n. 1, p. 5 -36, 2008.
PRATELLI, A.; CAVALLI, A.; MARTELLA, V.; TEMPESTA, M.; DECARO, N.; CARMICHAEL, L.; BUONAVOGLIA, C. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clinical and Diagnostic
PULENDRAN, B.; AHMED, R. Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development. Cell, v. 124, n. 4, p. 849-863, 2006.
PFIZER VACCINES / Canine Parvovirus – VANGUARD PLUS acesso em 30/08/2012; endereço eletrônico:
https://animalhealth.pfizer.com/sites/pahweb/US/EN/Products/Pages/CADVacci
nesParvo.aspx.
RASKOVIC, P. Step-by-step process integration method for the improvements and optimization of sodium tripolyphosphate process plant. Energy, v. 32, n. 6, p. 983-998, 2007.
REED, A. P.; JONES, E. V.; MILLER, T. J. Nucleotide sequence and genome organization of canine parvovirus. Journal of Virology, v. 62 (1), p. 266-276, 1988.
RUPPRECHT, C. E.; HANLON, C. A.; BLANTON, J.; MANANGAN,J.;
MORRILL, P.; MURPHY, S.; NIEZGODA, M.; ORCIARI, L. A.; SCHUMACHER, C.L.; DIETZSCHOLD. Oral vaccination of dogs with recombinant rabies virus SIEGRIST, C. Neonatal and early life vaccinology. Vaccine, v. 19, n. 25-26, p. 3331-3346, 2005.
SAMBROOK, J.; FRITSCH, E. F.; MANIATIS, T. Molecular Cloning: a
laboratorymanual. 2 ed. New York: Cold Spring Harbor Laboratory Press,
957p, 1989.
SIEGL, G. Canine parvovirus: origin and significance of a “new” pathogen. In:
Berns, K. I. The Parvoviruses New York, Plenum Publishing Corp., p. 363-
388, 1984.
SIEGRIST, C. Neonatal and early life vaccinology. Vaccine, v. 19, n. 25-26, p. 3331-3346, 2001.
SILVA, A.R.. Análise da cinética de replicação do parvovírus canino em cultivo de células CRFK através da PCR em tempo real. 2011. 106 f. Dissertação (Mestrado) – Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo (USP), São Paulo. 2011.
SINGH, M.; VAJDY, M.; GARDNER, J.; BRIONES, M.; O'HAGAN, D. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine, v. 20, n. 3-4, p. 594-602, 2001.
SKOOG, D. A.; WEST, D. M.; HOLLER, F. J. ; Princípios de Análise Instrumental, 5ª ed., Bookman: Porto Alegre, 2002.
SMART, J.D. The basics and underlying mechanisms of mucoadhesion,
Advanced Drug Delivery Reviews, v. 57, p.1556-1568, 2005.
SONG, J.H.; NGUYEN, H.H.; ÇUBURU, N.; HORIMOTO, T.; KO, S.Y.; PARK, S.H.; CZERKINSKY, C.; KWEON, M.N. Sublingual vaccination with influenza virus protects mice against lethal viral infection. PNAS, p. 1644-9, 2008.
STAATS, H. F.; JACKSON, R. J.; MARINARO, M.; ET AL. Mucosal immunity to infection with implications for vaccine development. Current Opinion in
Immunology, v. 6, n. 4, p. 572-583, 1994.
STROMBECK, D.R.; GUILFORD, W.G. Small animal gastroenterology. 2.ed. USA: wolfe publishing Limited, p.280-313, 1991.
TAKAHASHI, I.; NOCHI, T.; YUKI, Y.; KIYONO, H. New horizon of mucosal immunity and vaccines. Current Opinion in Immunology, v. 21, n. 3, p. 352- 358, 2009.
TAMS, T.R. Handbook of small animal gastroenterology. Philadelphia: W.B. Saunders Company, p.246-265, 1996.
THAPA, P.; BAILLIE, A. J.; STEVENS, H. N. E. Lyophilization of Unit Dose Pharmaceutical Dosage Forms. Drug Development and Industrial Pharmacy, v. 29, n. 5, p. 595, 2003.
TOMASI, T.B. The discovery of secretory IgA and the mucosal immune system.
Immunology Today, 13: 416-418, 1962.
TOMASI, T.B.; TAN E.; SOLOMON, A.; PRENDERGAST, J.C. Charactheristic of an immune system common to certain external secretions.The Journal of
Experimental Medicine, 121: 107-124, 1965.
TRUYEN, U. Evolution of canine parvovirus--a need for new vaccines?
Veterinary Microbiology, v. 117, n. 1, p. 9-13, 2006.
TSAI, M.; CHEN, R.; BAI, S.; CHEN, W. The storage stability of
chitosan/tripolyphosphate nanoparticles in a phosphate buffer. Carbohydrate
Polymers, v.84, n. 2, p. 756-761, 2011.
TSAO, J.; CHAPMAN, M.S.; AGBANDJE, M.; KELLER, W.; SMITH, K.; WU, H.; LUO, M.; SMITH, T. J.; ROSSMANN, M. G.; COMPANS, R. W. The three dimensional structure of canine parvovirus and its functional implications.
Science. 251 (5000), p. 1456-1464, 1991.
TURVEY, S. E.; BROIDE, D. H. Innate immunity. Journal of Allergy and
ULLRICH, S. Skin Immunology and Immunotoxicity. In: Comprehensive
Toxicology. p.217-234, 2010. Oxford: Elsevier. Disponível em:
<http://www.sciencedirect.com/science/article/B735M-50CM347- 4B/2/8e5ea1367f85a97de58a1ed3a2ca1612<. Acesso em: 18/1/2011
VAN DER LUBBEN, I. M.; VERHOEF, J. C.; BORCHARD, G.; JUNGINGER, H. E. Chitosan for mucosal vaccination. Advanced Drug Delivery Reviews, v. 52, n. 2, p. 139-144, 2001.
YANG, C.Y.; HSU, C.H.; TSAI, M.L. Effect of crosslinked condition on
characteristics of chitosan/tripolyphosphate/genipin beads and their application in the selective adsorption of phytic acid from soybean whey. Carbohydrate
Polymers, v. 86, n. 2, p. 659-665, 2011.
YULE, T. D.; ROTH, M. B.; DREIER, K.; JOHNSON, F. A.; DENSMORE, M. P.; SIMMONS, K.; FANTON, R. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine, v. 15, n. 6-7, p. 720-729. doi: 10.1016/S0264-410X(96)00232-0, 1997.
WANER, T.; NAVEH, A.; WUDOVSKY, I.; CARMICHAEL, L.E. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. Journal of Veterinary
Diagnostic Investigation, v.8 (4), p.427–32, 1996.
WANG, W. Lyophilization and development of solid protein pharmaceuticals.
International Journal of Pharmaceutics, v. 203, n. 1-2, p. 1-60, 2000.
WHEELER, A. W.; SHARIF, S. Sublingual delivery of vaccines: Can we enhance the immune response induced via this route? European Journal of
Pharmaceutical Sciences, v. 4, n. Supplement 1, p. S39, 1996.
WU, H.; ROSSMAN, M. The canine parvovirus empty capsid structure. Journal